Search hospitals > Florida > Tampa
Saint Joseph's Hospital/Children's Hospital-Tampa
Claim this profileTampa, Florida 33607
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Cancer
193 reported clinical trials
11 medical researchers
Summary
Saint Joseph's Hospital/Children's Hospital-Tampa is a medical facility located in Tampa, Florida. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Cancer and other specialties. Saint Joseph's Hospital/Children's Hospital-Tampa is involved with conducting 193 clinical trials across 366 conditions. There are 11 research doctors associated with this hospital, such as Don Eslin, MD, Vijaya K. Gadiyaram, Roberto Diaz, and Dana A. Obzut.Area of expertise
1Leukemia
Global LeaderStage II
NTRK1 positive
NTRK positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Don Eslin, MDSaint Joseph's Hospital/Children's Hospital-Tampa7 years of reported clinical research
Expert in Tumors
Expert in Lymphoma
58 reported clinical trials
114 drugs studied
Vijaya K. GadiyaramMorton Plant Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
24 drugs studied
Roberto DiazMoffitt Cancer Center1 year of reported clinical research
Studies Breast Cancer
5 reported clinical trials
11 drugs studied
Dana A. ObzutSaint Joseph's Hospital/Children's Hospital-Tampa15 years of reported clinical research
Studies Tumors
Studies Childhood Cancer
4 reported clinical trials
10 drugs studied
Clinical Trials running at Saint Joseph's Hospital/Children's Hospital-Tampa
Breast Cancer
Germ Cell Tumors
Osteosarcoma
Langerhans Cell Histiocytosis
Brain Tumor
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Acute Leukemia
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Joseph's Hospital/Children's Hospital-Tampa?
Saint Joseph's Hospital/Children's Hospital-Tampa is a medical facility located in Tampa, Florida. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Cancer and other specialties. Saint Joseph's Hospital/Children's Hospital-Tampa is involved with conducting 193 clinical trials across 366 conditions. There are 11 research doctors associated with this hospital, such as Don Eslin, MD, Vijaya K. Gadiyaram, Roberto Diaz, and Dana A. Obzut.